Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,249

Why Aging is a Disease With David Sinclair | EP #18 Moonshots and Mindsets

In this episode, David and Peter discuss aging as a disease, the technology needed to reverse aging, and tips and tricks to increase your lifespan.

David Sinclair is a biologist and academic known for his expertise in aging and epigenetics. Sinclair is a genetics professor and the Co-Director of Harvard Medical School’s Paul F. Glenn Center for Biology of Aging Research. He’s been included in Time100 as one of the 100 Most Influential People in the World, and his research has been featured all over the media. Besides writing a New York Times Best Seller, David has co-founded several biotech companies, a science publication called Aging, and is an inventor of 35 patents.
Read David’s book, Lifespan: Why We Age-and Why We Don’t Have To: https://a.co/d/85H3Mll.

This episode is brought to you by Levels: real-time feedback on how diet impacts your health. https://levels.link/peter.

Consider a journey to optimize your mind and body by visiting http://mylifeforce.com/peter.

Read the Tech Blog: https://www.diamandis.com/blog.

Timestamps.

Continue reading “Why Aging is a Disease With David Sinclair | EP #18 Moonshots and Mindsets” | >

How the quantum realm will go beyond computing

Check out all the on-demand sessions from the Intelligent Security Summit here.

Over the last half-decade, quantum computing has attracted tremendous media attention. Why?

After all, we have computers already, which have been around since the 1940s. Is the interest because of the use cases? Better AI? Faster and more accurate pricing for financial services firms and hedge funds? Better medicines once quantum computers get a thousand times bigger?

Brain Tissue Study Uncovers New Genes Linked to Multiple Sclerosis

New research published in the Annals of Clinical and Translational Neurology on December 7 has identified three genes and their expressed proteins that may be involved in the pathogenesis of multiple sclerosis.

By comparing information on the genes and proteins expressed in the brains of thousands of individuals with and without multiple sclerosis, investigators discovered different expression levels of the SHMT1, FAM120B, and ICA1L genes (and their proteins) in brain tissues of patients versus controls.

Studying the functions of these genes may uncover new information on the mechanisms involved in the development and progression of multiple sclerosis. “Our findings shed new light on the pathogenesis of MS and prioritized promising targets for future therapy research,” the authors wrote.

Playing all the angles: A high-contrast grating structure for direction-tunable lasing

Lasers find applications across several fields ranging from telecommunications and remote sensing to medicine. There are many ways in which one can generate laser emission, or lasing, from a device or material. Consequently, there are many types of lasers with different principles of operation.

One emerging and promising method to achieve lasing with high energy efficiency is by leveraging what are known as “ in the continuum” (BICs). In simple terms, these states describe waves that remain highly localized in space but coexist with a continuous spectrum of waves that are not localized (traveling waves). When dealing with light, an , BICs can be realized by carefully designing the geometry of a confining periodic structure.

Although scientists have already reported a few types of BIC-based lasers, most of them can only emit a beam in a perfectly or almost perfectly vertical direction away from the surface of the device. This limitation hinders the use of such BIC lasers in applications where angling the emitted beam is necessary.

/* */